Total Payments
$681.51
2023 Payments
$115.13
Companies
8
Transactions
35
Medicare Patients
6,701
Medicare Billing
$291,931
Payment Breakdown by Category
Food & Beverage$681.51 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $681.51 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alimera Sciences, Inc. | $233.89 | 4 | $0 (2021) |
| PFIZER INC. | $138.86 | 9 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $115.13 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $50.98 | 3 | $0 (2021) |
| Amarin Pharma Inc. | $45.94 | 3 | $0 (2020) |
| Esperion Therapeutics, Inc. | $44.71 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $33.06 | 2 | $0 (2020) |
| Akcea Therapeutics, Inc. | $18.94 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $115.13 | 11 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($115.13) |
| 2022 | $45.01 | 3 | PFIZER INC. ($45.01) |
| 2021 | $316.06 | 9 | Alimera Sciences, Inc. ($214.15) |
| 2020 | $185.57 | 11 | Amarin Pharma Inc. ($45.94) |
| 2019 | $19.74 | 1 | Alimera Sciences, Inc. ($19.74) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/23/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/17/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.31 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/11/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/08/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.90 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/27/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.70 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/11/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/05/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.98 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/31/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.99 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/20/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/30/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/14/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/16/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/28/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2021 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/04/2021 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/13/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $149.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/21/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/22/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/23/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $31.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/17/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/27/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $33.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/15/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/11/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,492 | 1,681 | $259,428 | $54,927 |
| 2022 | 20 | 2,341 | 2,775 | $403,234 | $87,264 |
| 2021 | 15 | 2,044 | 2,292 | $446,076 | $109,023 |
| 2020 | 10 | 824 | 854 | $161,674 | $40,717 |
Total Patients
6,701
Total Services
7,602
Medicare Billing
$291,931
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 319 | 329 | $67,116 | $16,310 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 134 | $36,046 | $10,178 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 75 | 92 | $19,688 | $5,780 | 29.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 84 | 84 | $33,348 | $4,218 | 12.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 34 | 34 | $19,788 | $3,926 | 19.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $11,160 | $3,115 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 29 | 29 | $8,497 | $2,220 | 26.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 332 | 454 | $20,884 | $2,220 | 10.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 19 | $5,890 | $1,842 | 31.3% |
| 76376 | 3d radiographic procedure | Facility | 2023 | 153 | 157 | $5,495 | $1,095 | 19.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 91 | 92 | $13,800 | $804.73 | 5.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 17 | 35 | $3,115 | $745.28 | 23.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 51 | 51 | $6,630 | $660.76 | 10.0% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 66 | 66 | $2,178 | $590.20 | 27.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 29 | 29 | $2,059 | $511.56 | 24.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 15 | 16 | $1,232 | $321.28 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 11 | $1,628 | $294.51 | 18.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 19 | 19 | $874.00 | $95.55 | 10.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 408 | 416 | $84,864 | $18,973 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 224 | $60,256 | $17,820 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 85 | 105 | $22,549 | $6,866 | 30.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 51 | 52 | $30,264 | $6,757 | 22.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 113 | 113 | $44,861 | $5,954 | 13.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 696 | 1,022 | $47,012 | $5,669 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $20,832 | $5,615 | 27.0% |
About Dr. Dakshina Murthy, MD
Dr. Dakshina Murthy, MD is a Cardiovascular Disease healthcare provider based in New Martinsville, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801895016.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dakshina Murthy, MD has received a total of $681.51 in payments from pharmaceutical and medical device companies, with $115.13 received in 2023. These payments were reported across 35 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($681.51).
As a Medicare-enrolled provider, Murthy has provided services to 6,701 Medicare beneficiaries, totaling 7,602 services with total Medicare billing of $291,931. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location New Martinsville, WV
- Active Since 07/19/2005
- Last Updated 04/18/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1801895016
Products in Payments
- ILUVIEN (Drug) $214.15
- LifeVest (Device) $115.13
- ELIQUIS (Drug) $86.86
- VYNDAQEL (Drug) $52.00
- BRILINTA (Drug) $50.98
- Vascepa (Drug) $45.94
- NEXLETOL (Drug) $44.71
- XARELTO (Drug) $33.06
- Iluvien (Drug) $19.74
- TEGSEDI (Drug) $18.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.